HB570 (2025) Detail

(New Title) repealing the prescription drug affordability board.


HB 570-FN - AS AMENDED BY THE HOUSE

 

13Mar2025... 0190h

2025 SESSION

25-0079

05/02

 

HOUSE BILL 570-FN

 

AN ACT repealing the prescription drug affordability board.

 

SPONSORS: Rep. Edwards, Rock. 31; Sen. Rosenwald, Dist 13

 

COMMITTEE: Executive Departments and Administration

 

─────────────────────────────────────────────────────────────────

 

AMENDED ANALYSIS

 

This bill repeals the prescription drug affordability board.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

13Mar2025... 0190h 25-0079

05/02

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Twenty Five

 

AN ACT repealing the prescription drug affordability board.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

1  Salaries Established.  Amend RSA 94:1-a, I(b) by deleting in GG:

GG Department of heath and human services executive director, prescription

drug affordability board

2  Repeal.  The following are repealed:

I.  RSA 6:12, I(b)(384), relative to the New Hampshire prescription drug affordability board administration fund.

II.  RSA 126-BB, relative to the prescription drug affordability board.

3  Effective Date.  This act shall take effect July 1, 2025.

 

LBA

25-0079

Amended 8/20/25

 

HB 570-FN- FISCAL NOTE

AS AMENDED BY THE HOUSE (AMENDMENT #2025-0190h)

 

AN ACT repealing the prescription drug affordability board.

 

FISCAL IMPACT:   This bill does not provide funding.

 

 

Estimated State Impact

 

FY 2025

FY 2026

FY 2027

FY 2028

Revenue

$0

$0

$0

$0

Revenue Fund(s)

None

Expenditures*

$0

$0

$0

$0

Funding Source(s)

None

Appropriations*

$0

$0

$0

$0

Funding Source(s)

None

*Expenditure = Cost of bill                *Appropriation = Authorized funding to cover cost of bill

 

 

METHODOLOGY:

This bill repeals the Prescription Drug Affordability Board. The bill will have no fiscal impact, as the Board has already been repealed by HB 2 from the 2025 session, codified as Chapter 141:312-313, Laws of 2025.

 

AGENCIES CONTACTED:

None

 

Amendments

Date Amendment
March 5, 2025 2025-0190h

Links


Date Body Type
Jan. 29, 2025 House Hearing
Feb. 19, 2025 House Exec Session
Feb. 19, 2025 House Floor Vote
April 1, 2025 House Exec Session

Bill Text Revisions

HB570 Revision: 47432 Date: Aug. 20, 2025, 2:01 p.m.
HB570 Revision: 47213 Date: March 5, 2025, 1:14 p.m.
HB570 Revision: 46443 Date: Jan. 15, 2025, 3:56 p.m.

Docket


April 2, 2025: Retained in Committee


March 26, 2025: Executive Session: 04/01/2025 10:00 am LOB 210-211


March 19, 2025: Division III Work Session: 03/21/2025 01:00 pm LOB 210-211


March 13, 2025: Referred to Finance 03/13/2025 HJ 8 P. 76


March 13, 2025: Ought to Pass with Amendment 2025-0190h: MA DV 205-168 03/13/2025 HJ 8 P. 76


March 13, 2025: Amendment # 2025-0190h (NT): AA VV 03/13/2025 HJ 8 P. 74


March 13, 2025: Lay HB 570 on Table (Rep. Grote): MF RC 167-207 03/13/2025 HJ 8 P. 74


March 5, 2025: Minority Committee Report: Inexpedient to Legislate


March 5, 2025: Majority Committee Report: Ought to Pass with Amendment # 2025-0190h (NT) 02/19/2025 (Vote 9-7; RC)


Feb. 12, 2025: Executive Session: 02/19/2025 02:00 pm LOB 306-308


Jan. 22, 2025: Public Hearing: 01/29/2025 02:00 pm LOB 306-308


Jan. 16, 2025: Introduced (in recess of) 01/09/2025 and referred to Executive Departments and Administration HJ 3 P. 17